News | April 24, 2023
Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Several late-stage pipeline products have the potential to address some of these unmet needs
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
India has a pivotal role in eliminating TB
Subscribe To Our Newsletter & Stay Updated
